Evolent Historical Income Statement

EVH Stock

USD 27.10 0.31 1.13%

Historical analysis of Evolent Health income statement accounts such as Gross Profit of 483.5 M or Other Operating Expenses of 2.1 B can show how well Evolent Health performed in making a profits. Evaluating Evolent Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Evolent Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Evolent Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evolent Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

About Evolent Income Statement Analysis

Evolent Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Evolent Health shareholders. The income statement also shows Evolent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Evolent Health Income Statement Chart

Evolent Health Income Statement is one of the three primary financial statements used for reporting Evolent's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Evolent Health revenue and expense. Evolent Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.

As of now, Evolent Health's Other Operating Expenses is increasing as compared to previous years. The Evolent Health's current EBITDA is estimated to increase to about 48.7 M, while Operating Income is projected to decrease to (74.8 M).

Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Selling General Administrative

Total Revenue

Total revenue comprises all receipts Evolent Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Evolent Health minus its cost of goods sold. It is profit before Evolent Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Evolent Health. It is also known as Evolent Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Evolent Health income statement and represents the costs associated with goods and services Evolent Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Evolent Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Other Operating Expenses is increasing as compared to previous years. The Evolent Health's current EBITDA is estimated to increase to about 48.7 M, while Operating Income is projected to decrease to (74.8 M).

	2021	2022	2023	2024 (projected)
Total Revenue	908.0M	1.4B	2.0B	2.1B
Depreciation And Amortization	60.0M	67.2M	123.4M	129.6M

Total Revenue Depreciation And Amortization

Evolent Health income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Selling General Administrative	Research Development	Net Income From Continuing Ops	Non Recurring	Minority Interest	Tax Provision	Interest Income	Non Operating Income Net Other	Net Interest Income	Reconciled Depreciation	Discontinued Operations
Depreciation And Amortization		0.99	0.96	0.99	-0.13	0.03	0.37	0.98	0.79	-0.51	-0.47	-0.4	-0.88	0.96	0.77	0.81	-0.36	0.84	-0.61	-0.95	-0.67	-0.74	-0.95	0.89	-0.43
Total Revenue	0.99		0.96	1.0	-0.12	0.04	0.37	1.0	0.78	-0.5	-0.46	-0.39	-0.89	0.95	0.76	0.82	-0.35	0.84	-0.6	-0.95	-0.64	-0.72	-0.94	0.89	-0.43
Gross Profit	0.96	0.96		0.96	-0.19	0.03	0.36	0.92	0.9	-0.59	-0.52	-0.5	-0.77	0.87	0.9	0.89	-0.45	0.88	-0.71	-0.89	-0.78	-0.84	-0.86	0.84	-0.43
Other Operating Expenses	0.99	1.0	0.96		-0.15	0.03	0.37	0.99	0.8	-0.52	-0.47	-0.41	-0.88	0.94	0.78	0.84	-0.37	0.85	-0.63	-0.95	-0.67	-0.75	-0.93	0.89	-0.43
Operating Income	-0.13	-0.12	-0.19	-0.15		-0.12	-0.16	-0.1	-0.29	0.46	0.32	0.36	0.25	-0.02	-0.32	-0.28	0.44	0.03	0.5	0.34	0.45	0.44	-0.02	-0.05	-0.34
Ebit	0.03	0.04	0.03	0.03	-0.12		0.94	0.04	0.02	-0.59	-0.7	-0.6	-0.14	0.04	0.03	0.03	-0.63	0.08	0.2	-0.06	-0.29	-0.25	-0.05	0.02	-0.22
Ebitda	0.37	0.37	0.36	0.37	-0.16	0.94		0.37	0.29	-0.73	-0.81	-0.7	-0.43	0.36	0.29	0.31	-0.71	0.37	-0.03	-0.37	-0.5	-0.48	-0.37	0.32	-0.35
Cost Of Revenue	0.98	1.0	0.92	0.99	-0.1	0.04	0.37		0.72	-0.47	-0.43	-0.34	-0.91	0.95	0.7	0.78	-0.31	0.82	-0.55	-0.95	-0.59	-0.67	-0.95	0.89	-0.42
Total Operating Expenses	0.79	0.78	0.9	0.8	-0.29	0.02	0.29	0.72		-0.61	-0.53	-0.56	-0.55	0.65	0.98	0.93	-0.52	0.9	-0.79	-0.72	-0.84	-0.9	-0.65	0.77	-0.41
Income Before Tax	-0.51	-0.5	-0.59	-0.52	0.46	-0.59	-0.73	-0.47	-0.61		0.98	0.98	0.49	-0.48	-0.65	-0.49	0.98	-0.49	0.31	0.51	0.65	0.68	0.46	-0.46	0.28
Total Other Income Expense Net	-0.47	-0.46	-0.52	-0.47	0.32	-0.7	-0.81	-0.43	-0.53	0.98		0.97	0.43	-0.47	-0.56	-0.4	0.97	-0.46	0.2	0.43	0.6	0.61	0.46	-0.43	0.4
Net Income	-0.4	-0.39	-0.5	-0.41	0.36	-0.6	-0.7	-0.34	-0.56	0.98	0.97		0.34	-0.37	-0.61	-0.4	0.99	-0.44	0.23	0.36	0.6	0.62	0.36	-0.36	0.32
Income Tax Expense	-0.88	-0.89	-0.77	-0.88	0.25	-0.14	-0.43	-0.91	-0.55	0.49	0.43	0.34		-0.86	-0.53	-0.65	0.33	-0.63	0.33	0.96	0.43	0.5	0.84	-0.83	0.09
Interest Expense	0.96	0.95	0.87	0.94	-0.02	0.04	0.36	0.95	0.65	-0.48	-0.47	-0.37	-0.86		0.63	0.64	-0.33	0.76	-0.47	-0.89	-0.54	-0.59	-1.0	0.88	-0.5
Selling General Administrative	0.77	0.76	0.9	0.78	-0.32	0.03	0.29	0.7	0.98	-0.65	-0.56	-0.61	-0.53	0.63		0.9	-0.56	0.86	-0.78	-0.7	-0.85	-0.9	-0.63	0.72	-0.38
Research Development	0.81	0.82	0.89	0.84	-0.28	0.03	0.31	0.78	0.93	-0.49	-0.4	-0.4	-0.65	0.64	0.9		-0.37	0.91	-0.78	-0.8	-0.81	-0.88	-0.64	0.77	-0.33
Net Income From Continuing Ops	-0.36	-0.35	-0.45	-0.37	0.44	-0.63	-0.71	-0.31	-0.52	0.98	0.97	0.99	0.33	-0.33	-0.56	-0.37		-0.38	0.23	0.35	0.6	0.61	0.32	-0.31	0.28
Non Recurring	0.84	0.84	0.88	0.85	0.03	0.08	0.37	0.82	0.9	-0.49	-0.46	-0.44	-0.63	0.76	0.86	0.91	-0.38		-0.63	-0.74	-0.73	-0.79	-0.78	0.87	-0.57
Minority Interest	-0.61	-0.6	-0.71	-0.63	0.5	0.2	-0.03	-0.55	-0.79	0.31	0.2	0.23	0.33	-0.47	-0.78	-0.78	0.23	-0.63		0.58	0.85	0.86	0.46	-0.46	0.34
Tax Provision	-0.95	-0.95	-0.89	-0.95	0.34	-0.06	-0.37	-0.95	-0.72	0.51	0.43	0.36	0.96	-0.89	-0.7	-0.8	0.35	-0.74	0.58		0.62	0.69	0.87	-0.86	0.19
Interest Income	-0.67	-0.64	-0.78	-0.67	0.45	-0.29	-0.5	-0.59	-0.84	0.65	0.6	0.6	0.43	-0.54	-0.85	-0.81	0.6	-0.73	0.85	0.62		0.98	0.53	-0.5	0.46
Non Operating Income Net Other	-0.74	-0.72	-0.84	-0.75	0.44	-0.25	-0.48	-0.67	-0.9	0.68	0.61	0.62	0.5	-0.59	-0.9	-0.88	0.61	-0.79	0.86	0.69	0.98		0.58	-0.57	0.46
Net Interest Income	-0.95	-0.94	-0.86	-0.93	-0.02	-0.05	-0.37	-0.95	-0.65	0.46	0.46	0.36	0.84	-1.0	-0.63	-0.64	0.32	-0.78	0.46	0.87	0.53	0.58		-0.9	0.55
Reconciled Depreciation	0.89	0.89	0.84	0.89	-0.05	0.02	0.32	0.89	0.77	-0.46	-0.43	-0.36	-0.83	0.88	0.72	0.77	-0.31	0.87	-0.46	-0.86	-0.5	-0.57	-0.9		-0.4
Discontinued Operations	-0.43	-0.43	-0.43	-0.43	-0.34	-0.22	-0.35	-0.42	-0.41	0.28	0.4	0.32	0.09	-0.5	-0.38	-0.33	0.28	-0.57	0.34	0.19	0.46	0.46	0.55	-0.4

Click cells to compare fundamentals

Evolent Health Account Relationship Matchups

Evolent Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	54.9M	61.5M	60.0M	67.2M	123.4M	129.6M
Total Revenue	846.4M	1.0B	908.0M	1.4B	2.0B	2.1B
Gross Profit	333.3M	321.1M	250.4M	316.6M	460.5M	483.5M
Other Operating Expenses	966.8M	1.1B	937.1M	1.4B	2.0B	2.1B
Operating Income	(120.4M)	(37.9M)	30.2M	(59.8M)	(71.2M)	(74.8M)
Ebit	(120.4M)	(37.9M)	30.2M	(59.8M)	(77.0M)	(80.9M)
Ebitda	(65.5M)	23.6M	90.3M	7.4M	46.4M	48.7M
Cost Of Revenue	513.1M	701.4M	657.6M	1.0B	1.5B	1.6B
Total Operating Expenses	453.7M	372.0M	279.5M	336.5M	481.5M	254.9M
Income Before Tax	(327.1M)	(337.8M)	(29.8M)	(62.1M)	(202.4M)	(192.3M)
Total Other Income Expense Net	(206.7M)	(299.9M)	(60.0M)	(2.2M)	(132.4M)	(125.8M)
Net Income	(305.6M)	(334.2M)	(30.3M)	(18.7M)	(113.0M)	(107.4M)
Income Tax Expense	(21.5M)	(3.6M)	483K	(43.4M)	(89.4M)	(84.9M)
Interest Expense	14.5M	28.3M	25.4M	15.6M	54.2M	56.9M
Selling General Administrative	392.8M	310.6M	219.5M	245.7M	358.1M	236.7M
Research Development	19.8M	15.1M	15.5M	27M	26.7M	16.2M
Net Income From Continuing Ops	(302.0M)	(334.2M)	(30.3M)	(18.7M)	(113.0M)	(118.7M)
Net Income Applicable To Common Shares	(302.0M)	(334.2M)	(37.6M)	(19.2M)	(17.2M)	(18.1M)
Minority Interest	(1.5M)	(3.6M)	2.0M	(822K)	(739.8K)	(702.8K)
Tax Provision	(21.5M)	(3.6M)	483K	(43.4M)	(89.4M)	(84.9M)
Interest Income	4.0M	3.2M	407K	9.6M	5.3M	4.9M
Non Operating Income Net Other	(5.5M)	(38.7M)	13.6M	6.0M	5.4M	5.1M
Net Interest Income	(10.5M)	(25.2M)	(25.0M)	(14.2M)	(48.9M)	(46.5M)
Reconciled Depreciation	60.9M	61.5M	60.0M	67.2M	123.4M	70.7M
Extraordinary Items	1.6M	3.6M	(7.3M)	(463K)	(416.7K)	(437.5K)

Pair Trading with Evolent Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.

Moving against Evolent Stock

0.57

EUDA

EUDA Health Holdings

Pair Corr

The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.

The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:

How To Invest In Evolent

Details

Is Evolent Stock a good investment?

Details

What is Evolent Health's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Stocks Directory Find actively traded stocks across global markets

Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.28)

Revenue Per Share

17.653

Quarterly Revenue Growth

0.454

Return On Assets

0.0086

Return On Equity

(0.11)

The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolent Historical Income Statement

About Evolent Income Statement Analysis

Evolent Health Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Evolent Health income statement Correlations

Evolent Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Evolent Health income statement Accounts

Pair Trading with Evolent Health

Moving against Evolent Stock

Complementary Tools for Evolent Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Total Revenue	+ 0.99	Depreciation And Amortization
Other Operating Expenses	+ 0.99	Depreciation And Amortization
Cost Of Revenue	+ 0.99	Other Operating Expenses
Net Income From Continuing Ops	+ 0.99	Net Income

Net Interest Income	- 1.0	Interest Expense
Net Interest Income	- 0.95	Cost Of Revenue
Tax Provision	- 0.95	Cost Of Revenue
Tax Provision	- 0.95	Other Operating Expenses
Tax Provision	- 0.95	Total Revenue
Net Interest Income	- 0.95	Depreciation And Amortization